Join Strados at ATS 2025!

Learn More
Strados Logo
  • Technology
    • The RESP® Biosensor
      • For Remote Patient Monitoring »
      • For Clinical Trials & Research »
  • Therapeutic Areas
    • Asthma
    • Chronic Cough
    • COPD
    • Pulmonary Fibrosis
  • About
  • Resources
    • News
    • Insights
    • Publications
    • Research Grant
  • Contact
Join Strados Labs’ Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher

Join Strados Labs’ Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher

by Strados Labs | May 1, 2025 | Events

Please join Strados Labs at ATS 2025 for an engaging session on the often-overlooked symptom of cough in pulmonary fibrosis, led by Dr Toby Maher, Professor of Clinical Medicine at Keck School of Medicine, USC. Tuning In To Cough In Pulmonary Fibrosis: How Should We...
Strados Labs to Present Developments in Cough Monitoring at ATS 2025

Strados Labs to Present Developments in Cough Monitoring at ATS 2025

by Strados Labs | Apr 22, 2025 | Events, Press Releases

Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference from May 16–21 in San Francisco, CA. Please join us as we present sessions highlighting the importance of cough in respiratory diseases, along...
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring

Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring

by Strados Labs | Mar 25, 2025 | Press Releases

The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained

Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained

by Strados Labs | Mar 11, 2025 | Blog - Clinical Trial Focus

Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects’ cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema

Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema

by Strados Labs | Feb 20, 2025 | Press Releases

The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
« Older Entries

Recent Posts

  • Join Strados Labs’ Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher
  • Strados Labs to Present Developments in Cough Monitoring at ATS 2025
  • Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
  • Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
  • Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema
Strados
Making Every Breath Count™
Offices
Philadelphia, PA
Atlanta, GA

Sitemap

  • About Strados
  • Support
  • Contact
  • Publications
  • Technical Specifications
  • FAQ
  • Careers

Follow Us





Get In Touch

1-888-STRADOS
Info@stradoslabs.com

Stay updated with news and insights!

Success!

Submit

© 2025 Strados Labs®  |  Privacy Policy  |   Cookie Policy